Gilead Sciences
GILD
#95
Rank
S$234.60 B
Marketcap
S$189.09
Share price
4.02%
Change (1 day)
29.79%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.54

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.24. In 2024 the company made an earnings per share (EPS) of S$0.48 a decrease over its 2023 EPS that were of S$5.75.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.541676.65%
2024S$0.48-91.65%
2023S$5.7523.98%
2022S$4.64-25.86%
2021S$6.264850%
2020S$0.13-97.64%
2019S$5.360.9%
2018S$5.3118.71%
2017S$4.48-64.88%
2016S$12.75-18.45%
2015S$15.6355.28%
2014S$10.06296.02%
2013S$2.5417.89%
2012S$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.08 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.72-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.02-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.11 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.12 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$13.90 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.65-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$18.12 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.24 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA